Dietary fat alters body composition, mammary development, and cytochrome P450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive Aryl hydrocarbon receptors

Environmental Health Perspectives

Volumn 117, Issue 9, 2009, Pages 1414-1419

  La Merrill, Michele ^a   Kuruvilla, Bittu S ^a   Pomp, Daniel ^a   Birnbaum, Linda S ^b,d   Threadgill, David W ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); Aryl hydrocarbon receptor; Fetal loss; Gene environment interactions; Mouse; Obesity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIMETHYLBENZ[A]ANTHRACENE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH; BODY COMPOSITION; BODY FAT; BODY MASS; BREAST DEVELOPMENT; CONTROLLED STUDY; DBA 2 MOUSE; DIET RESTRICTION; ENVIRONMENTAL EXPOSURE; ENZYME INDUCTION; FAT INTAKE; FEMALE; GESTATION PERIOD; GLUCOSE BLOOD LEVEL; LIPID DIET; LITTER SIZE; MOUSE; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PUERPERIUM; SURVIVAL RATE;

ANIMALS; BODY COMPOSITION; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY FATS; ENZYME INDUCTION; FEMALE; MAMMARY GLANDS, ANIMAL; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PREGNANCY; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 69949095071     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800530     Document Type: Article

References (45)

1. Abbott BD, Schmid JE, Pitt JA, Buckalew AR, Wood CR, Held GA, et al. 1999. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol Appl Pharmacol 155(1):62-70.
2. Britton JA, Wolff MS, Lapinski R, Forman J, Hochman S, Kabat GC, et al. 2004. Characteristics of pubertal development in a multi-ethnic population of nine-year-old girls. Ann Epidemiol 14(3):179-187.
3. Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. 1998. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19(9):1623-1629.
4. Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, et al. 1999. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96(5):1977-1982.
5. Carmichael AR. 2006. Obesity and prognosis of breast cancer. Obes Rev 7(4):333-340.
6. Chang C, Smith DR, Prasad VS, Sidman CL, Nebert DW, Puga A. 1993. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3(6):312-321.
7. Chapman DE, Schiller CM. 1985. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 78(1):147-157.
8. Ciarloni L, Mallepell S, Brisken C. 2007. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA 104(13):5455-5460. Consonni D, Pesatori AC, Zocchetti C, Sindaco R, DiOro LC, Rubagotti M, et al. 2008. Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25 years of follow-up. Am J Epidemiol 167(7):847-858.
9. Cranmer M, Louie S, Kennedy RH, Kern PA, Fonseca VA. 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 56(2):431-436.
10. Den Hond E, Roels HA, Hoppenbrouwers K, Nawrot T, Thijs L, Vandermeulen C, et al. 2002. Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ Health Perspect 110:771-776.
11. DeVito MJ, Diliberto JJ, Ross DG, Emond C, Richardson VM, Birnbaum LS. 2003. Influence of type II diabetes and obesity on the disposition and elimination of TCDD in mice [Abstract]. In: Proceedings of the 42nd Annual SOT Meeting, 9-13 March 2003, Salt Lake City, UT. Reston, VA:Society of Toxicology.
12. Emond C, Birnbaum LS, DeVito MJ. 2006. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Environ Health Perspect 114:1394-1400.
13. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. 2008. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 14(4):570-581.
14. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. 2002. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 67(1):63-74.
15. Fujiyoshi PT, Michalek JE, Matsumura F. 2006. Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam War. Environ Health Perspect 114:1677-1683.
16. Galvan N, Jaskula-Sztul R, MacWilliams PS, Czuprynski CJ, Jefcoate CR. 2003. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol Appl Pharmacol 193(1):84-96.
17. Galvan N, Teske DE, Zhou G, Moorthy B, MacWilliams PS, Czuprynski CJ, et al. 2005. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-dimethyl-benz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol Appl Pharmacol 202(3):244-257.
18. Goldman LR, Harnly M, Flattery J, Patterson DGJ, Needham LL. 2000. Serum polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans among people eating contaminated home-produced eggs and beef. Environ Health Perspect 108:13-19.
19. Hakkak R, MacLeod S, Shaaf S, Holley AW, Simpson P, Fuchs G, et al. 2007. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Int J Oncol 30(3):557-563.
20. Han DF, Zhou X, Hu MB, Wang CH, Xie W, Tan XD, et al. 2004. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol Lett 150(2):167-177.
21. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. 1997. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8(3):252-258.
22. Himes JH, Obarzanek E, Baranowski T, Wilson DM, Rochon J, McClanahan BS. 2004. Early sexual maturation, body composition, and obesity in African-American girls. Obes Res 12(suppl):64S-72S.
23. Hoppe AA, Carey GB. 2007. Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring) 15(12):2942-2950.
24. Howlin J, McBryan J, Martin F. 2006. Pubertal mammary gland development: insights from mouse models. J Mammary Gland Biol Neoplasia 11(3-4):283-297.
25. Korah R, Das K, Lindy ME, Hameed M, Wieder R. 2007. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Hum Pathol 38(1):154-160.
26. LaKind JS, Amina Wilkins A, Berlin CM Jr. 2004. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol 198(2):184-208.
27. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408.
28. Lorincz AM, Sukumar S. 2006. Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279-292.
29. Michalek JE, Tripathi RC. 1999. Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 15-year follow-up. J Toxicol Environ Health A57(6):369-378.
30. Moral R, Solanas M, Garcia G, Colomer R, Escrich E. 2003. Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomas. Oncol Rep 10(5):1417-1424.
31. Moriguchi T, Motohashi H, Hosoya T, Nakajima O, Takahashi S, Ohsako S, et al. 2003. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci USA 100(10):5652-5657.
32. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279(23):23847-23850.
33. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13):1549-1555.
34. Patel RD, Kim DJ, Peters JM, Perdew GH. 2006. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci 89(1):75-82.
35. Poland A, Glover E. 1980. 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus. Mol Pharmacol 17(1):86-94.
36. Postlind H, Vu TP, Tukey RH, Quattrochi LC. 1993. Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 118(2):255-262.
37. Sato S, Tomita I. 1998. Response differences among mouse strains in DNA damage and skin carcinogenicity of 7,12-dimethylbenz[a]anthracene are due to inducible aryl hydrocarbon hydroxylase activity. Biol Pharm Bull 21(1):90-92.
38. Shimba S, Hayashi M, Ohno T, Tezuka M. 2003. Transcriptional regulation of the AhR gene during adipose differentiation. Biol Pharm Bull 26(9):1266-1271.
39. Silberstein GB. 2001. Postnatal mammary gland morphogenesis. Microsc Res Tech 52(2):155-162.
40. Slyper AH. 2006. The pubertal timing controversy in the USA, and a review of possible causative factors for the advance in timing of onset of puberty. Clin Endocrinol (Oxf) 65(1):1-8.
41. Thomsen AR, Almstrup K, Nielsen JE, Sorensen IK, Petersen OW, Leffers H, et al. 2006. Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile. Toxicol Sci 93(2):357-368.
42. Tsuchiya Y, Nakajima M, Yokoi T. 2005. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227(2):115-124.
43. Vorderstrasse BA, Fenton SE, Bohn AA, Cundiff JA, Lawrence BP. 2004. A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci 78:248-257.
44. Weber LW, Lebofsky M, Stahl BU, Smith S, Rozman KK. 1995. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 131(1):155-162.
45. Zhu BT, Gallo MA, Burger CW Jr, Meeker RJ, Cai MX, Xu S, et al. 2008. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high-fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice. Toxicol Appl Pharmacol 226(2):107-118.